In this installment of Atrial Fibrillation (AFib) and Antiarrhythmic Drugs (AADs) series, Dr. Suneet Mittal interviews Dr. Jeff Healey about evidence supporting the guidelines and how they compare to previous guidelines. Listen as Dr. Healey analyzes the utilization of AADs based on the 2023 guidelines.
This podcast is part of Early Onset of Atrial Fibrillation & the Contemporary Use of Antiarrhythmic Drugs grant initiative.
Educational grant support is provided by Sanofi. Click here for more: https://learn.acc.org/Page/LearnAntiarrhythmicDrugsforAF
Subscribe to CardiaCast | Claim CME Credit
